IOSPInnospec Inc.
Is the price fair?
Neither cheap nor expensive: cheap vs its sector, but priced for +11% a year vs −3% a year delivered.
Priced for ~11% a year FCF growth. The price already bakes in strong, sustained growth.
In its normal range: P/E 19.5 vs a 20.0 median over 40 quarters (−2% vs median).
Sector median 18.9× across 51 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What IOSP's price assumes
Innospec Inc. trades at 19.5× earnings against 29.4× for the median Specialty Chemicals name, cheaper than its own group.
Trailing P/E · Specialty Chemicals median 29.4 · cheaper than the typical name in its group
- Price / sales
- 1.15
Price / sales · today's price, fiscal year to Dec 31, 2025
- Free cash flow yield
- 3.4%
Free cash flow yield · Specialty Chemicals median 4.7%
- Growth the price implies
- +11%
Growth the price implies · The price pays for +11% free cash flow growth a year for a decade; the business has delivered −21% a year over the last three.
Details›
- Price / booktoday's price, fiscal year to Dec 31, 2025
- 1.54
- EV / EBITtoday's price, fiscal year to Dec 31, 2025
- 13.5
- EV / salestoday's price, fiscal year to Dec 31, 2025
- 0.98
- Basic Materials median P/E203 names
- 20.7
- Specialty Chemicals median P/E43 names
- 29.4
- Free cash flow, trailing twelve months
- $69M
- Market capitalisation
- $2.04B
- 3-year revenue growth
- −2.9%
- 3-year free cash flow growth
- −21%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $87.45 |
| Its own P/E history, median | $97.93 |
| Its own P/E history, upper quartile | $122.68 |
| 52-week range | $65.12 – $98.69 |
| Today | $95.59 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.